Thursday, 16 January 2020

Greenhouse Film Market Insights and In-Depth Analysis 2019-2026 with Types, Products and Key Players


New York, NY 16 Jan 2020 :The global greenhouse film market is estimated to reach USD 8.3 billion by 2026 growing at a CAGR of 9.8% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Greenhouse Film Market Share, Size, Trends, & Industry Analysis Report, By Resin Type (Low Density Polyethylene, Linear Low-Density Polyethylene, Polyvinyl Chloride), By Width (4.5M, 5.5 M, 7M, 9M), By Thickness, By Application, By Regions: Segment Forecast, 2019 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends. In 2018, the Low-Density Polyethylene segment accounted for the highest share in the global greenhouse film industry in terms of revenue. North America was the leading contributor to the global market revenue in 2018.

The increase in the population worldwide and growth in global food demand majorly drives the market growth. The ability to produce high quality crops throughout the year, lesser use of water for crop cultivation, improved crop quality, and increased level of control over crop growth boost the market growth. Growing urbanization, need to enhance agricultural yield, rising investments by government organizations on agricultural schemes, and increasing focus on nutritious food products and indoor farming accelerate the market growth. New emerging markets, technological advancements in farming methods, growing demand and area used for greenhouse protected cultivation would provide growth opportunities in the market in the coming years.


Polyethylene plastic is available in two different strengths; commercial grade for large industrial applications and utility grade for personal use. Polyethylene plastic usually lasts for a year or two. Polyvinyl Plastic is expensive, durable offer high strength. However, the most durable greenhouse plastic is polycarbonate plastic. It is a twin wall, polyethylene plastic that maintains heat and humidity with the ability to last for up to a decade.
  
In 2018, North America generated the highest market share in terms of revenue in the greenhouse film industry. The growing urbanization, and rising population has accelerated the market growth in the region. A significant rise in the demand for organic and chemical free food products supports the market growth in the region. The technological advancements in farming methods, and increasing need for controlled environment for high quality crops further improves the market growth rate. Asia-Pacific is expected to grow at the highest rate during the forecast period owing to significant growth of population, government schemes, and strong technical expertise in agricultural practices. Technological advancements and established R&D institutes in China and Japan further supports the market growth.


The well-known companies profiled in the Greenhouse Film market report include Polifilm Extrusion GmbH, Essen Multipack Limited, Ginegar Plastic Products Ltd, Beijing Kingpeng International Hi-Tech Corporation, Thai Charoen Thong Karntor Co., Ltd, Central Worldwide Co., Ltd, Berry Global Group, Inc., The Dow Chemicals Company, Agriplast SRL, and Lumite, Inc. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com



Monday, 13 January 2020

High Performance Composites Market Demand, recent trends, Major Driving Factors and Business Growth Strategies 2026


New York, NY 13 Jan 2020 : The global high-performance thermoplastics market size is estimated to reach USD 65.6 billion by 2026 according to a new report by Polaris Market Research. The report “High Performance Thermoplastics Market Size, Share & Industry Report By Product Type (Polyamides, Polyphenylsufone, Sulfone Polymers, Liquid Crystal Polymers, Aromatic Polyketones, Polyethersulfone), By Application (Electrical & Electronics, Automotive, Aircraft, Industrial), By Regions, & Segment Forecast, 2019 – 2026” provides competent analysis of current market position and portrays future market trends.

High Performance Thermoplastics are advanced polymeric solutions that abide by industry specific applications. Largely, the demand is driven by the increased application in interior and exterior aerospace and automotive structures. HPTP exhibits excellent properties such as high temperature resistance, high chemical resistance and superior mechanical properties under severe conditions. These properties make it ideal for use in such demanding conditions with a healthy market growth to boast.


HPTP’s are currently the material of choice to be used in aircrafts when over some decades back, major components in aircraft were assembled with aluminum as chief component. This aluminum has made way for high-performance plastics and high-performance carbon fibers. These high-performance thermoplastics are light-weight and resist high temperatures that lead to fuel optimizations.

High-performance thermoplastics are the desired material in large industries such as electrical and electronics and industrial applications. Thermoplastics have seen increasing demand in emerging economies such as India and China. A rousing demand in consumer electronic products has significantly attributed success to market growth in thermoplastics. A rising population on a global scale and increasing disposable incomes has powered demand for these products in end-use industries that include thriving growth for market. A sizeable middle-class population and growing urbanization has boosted demand for advanced and modern electrical and automotive products. The lower costs attributed to the product and advancements in product quality have significantly contributed to robust growth of high-performance thermoplastics.
  
The consequence of choosing the wrong material can prove costly. Aerospace and mass transit industries have a very negligible scope for errors and hence any component failure can only prove to be highly disastrous. High-performance thermoplastics are higher-priced but provide great thermal resistance than other engineering polymers. HTTP’s also provide greater thermal stability both in short and long run.


Asia Pacific is the leading player for high performance thermoplastics owing to high development of its constituent countries. Japan is a fast-growing and productive country that is leader in electrical and electronics industry which hold true for HPTP’s growth also. Europe and America also have taken gigantic strides in automotive and aircraft industries that impact the HPTP positively. MEA and Africa are tagged with positive market growth for HPTP market.

The players are competing on grounds of modification of existing polymer type via intensive Rand D efforts and processing techniques. The key players in High Performance Thermoplastics Market include BASF, DowDuPont, SABIC, Solvay, Victrex, Royal DSM, Asahi Kasei, DIC Corporation and Honeywell International, Inc.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Hematologic Malignancies Therapeutics Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026


New York, NY 13 Jan 2020 : The Global Hematologic Malignancies Therapeutics Market Size is anticipated to reach over USD 87.0 Billion by 2025 according to a new research published by Polaris Market Research. 

Hematological malignancy is a type of cancer that affect the bone marrow, blood, and lymph nodes. They include several forms of myeloma, leukemia, and lymphoma. According to an industry report in 2011, Hematological malignancies constituted 9% of all newly diagnosed malignancies in the U.S. specifying that lymphomas are more prevalent than myeloma or leukemias. Excluding Hodgkin’s lymphoma as well as acute lymphocytic leukemia, these types of malignancy are usually related to growing age. Hence, considering the aging worldwide population, malignancy type is more probable to become more prevalent.

The global Hematologic Malignancies Therapeutics Market growth is majorly driven by the increasing focus on development for novel treatments and growing occurrence of blood cancer. Currently, blood malignancies are the second most leading cause of cancer deaths and the 5th most common cancer. The three most common types of blood cancers are multiple myeloma leukemia, and lymphoma. Each year, approximately 400,000 people are diagnosed with lymphoma and more than 300,000 people are diagnosed with leukemia globally. In addition, inventions of novel drugs for blood cancer and its regulatory approvals are anticipated to bolster the market growth. For instance, in 2015, Pfizer announced that its antibody-drug conjugate- inotuzumab has received USFDA approval for acute lymphoblastic leukemia.  


The Global Hematologic Malignancies Therapeutics Market is segmented on the basis of type, therapy, and geography. Based on type, the market is segmented into leukemia, lymphoma, multiple myeloma, and others. The leukemia is further segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. On the basis of type, leukemia was estimated to dominate the market. The major market share is due to availability of products such as Imbruvica, Rituxan, and Glivec, which are estimated to be the highest revenue generating drugs. On the basis of therapy, the global Hematologic Malignancies Therapeutics Market is segmented into Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others. Amongst all the therapies, chemotherapy is the most commonly used treatment with a particular drug or combination of drugs used.
  
On the basis of region, the global Hematologic Malignancies Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global market. The dominance is majorly attributed to the high presence of key market players, availability of branded drugs, established healthcare organization, and increasing government support in the region. However, Asia Pacific is expected to dominate the global market during the forecast period. Increasing awareness about early diagnosis, availability of effective treatment in emerging countries, such as India and China, growing healthcare expenditure, and high unmet clinical needs of patients, are some of the factors anticipated to significantly boost the market in the Asia Pacific.


Some major key players in global Hematologic Malignancies Therapeutics Market includes Pfizer, Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, AbbVie, Inc., Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc., and Takeda Pharmaceutical Company limited among others. The object of the key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Geriatric Medicines Market Size 2026 | Top Companies, Trends, Growth Factors Details by Regions, Types and Applications


New York, NY 13 Jan 2020 : The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research. 

Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.

The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions.


Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.
  
The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography. On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.


North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Breast Lesion Localization Methods Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

New York, NY 13 Jan 2020 :The global breast lesion localization methods market is estimated to reach USD 1.98 billion by 2026 and is estimated to grow at a CAGR of 14.9% between 2018 to 2026 as per a new study published by Polaris Market Research. The report ‘Breast Lesion Localization Methods Market Size by Type (Wire Localization Biopsy, Radioisotope Localization (Radio-Guided Occult Lesion Localization, and Radioactive Seed Localization), Magnetic Tracer, and Others); and by Regions Segments & Forecast, 2018 – 2026’ provides a deep dive analysis and estimates the future trends.

The abnormal changes in breast cells due to injuries or problems is stated as breast lesion. Benign breast disease promotes the growth of tumors in non-cancerous areas wherein there is a rapid growth of breast cells forming lumps inside the breasts. However, on the other hand malignant lesions grow hysterically and are dangerous since they can be fatal. There is no particular age limit for this condition to occur in women however it is seen commonly during the reproductive years and majority of the complaints are from the women between the age group of 40 to 69 years old. The investigative analysis of this disease can be done by both physical examinations, studying patient’s medical history and by using ultrasound, mammography, MRI and through tissue sampling. If the examination evaluates that the growth is malignant then it is needed to execute lesion surgical treatment. Lesion localization devices are used to perform treatments on these ailments. The selection of ideal localization approach is additionally an essential choice as it is taken by medical professionals relying on the variety of elements consisting of efficiency, mean localization time, convenience of usage, expense of surgical treatment, security, and age of individual.

  
Rising instances of breast cancer across the globe is one of the major factors driving the overall breast lesion localization method market. According to American Institute for Cancer Research, there were 2 million new cases of breast cancer in 2018 with Belgium and Luxembourg to have most of the cases followed by Netherlands and France. Canada and U.S. also have a higher occurrences of breast cancer with approximately 84 among 100,000 individuals. This has made the governments of different countries to introduce compensation policies for diagnosis of mammary gland cancer, pre-surgical examinations, biopsy and other options of treatments. Due to increased breast cancer occurrences and rising awareness among the people have helped the market to grow globally thereby implementing breast lesion localization procedures.

Wire localization biopsy, commonly known as wire guided biopsy or needle localization, is estimated to control the breast lesion localization methods market in 2018.  This was majorly due to its increased usage by medical practitioners, growing implementation in hospitals and cancer diagnostic centers. Magnetic tracers on the other hand is anticipated to be one of the fastest growing segments within this market as there has been a significant adoption of new technology such as magnetic sentinel node and occult lesion localization (MagSNOLL) over traditional methods such as wire localization.


Radioisotope seed localization on the other hand is taken into consideration as one of the most favored approach among all radioisotope localization techniques because of its advantages such as simplicity of localization couple of weeks prior to the excision surgical procedure as well as minimal demand for re-operation. Early device adoption and a paradigm shift from traditional to scientifically advanced treatment procedures and products, the North American region is predicted to lead the market in 2018. This is followed by Asia Pacific region which is expected to grow at a higher rate due to increasing medical infrastructure, rise in the spending capacity of the people from countries such as India and China, growing awareness about breast cancer and large target population.

Some major key players in this industry include Argon Medical Devices, Inc., Cook Medical, Cianna Medical, CP Medical, Inc., C.R. BARD, Inc., STERYLAB, and SOMATEX Medical Technologies GmbH among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Thursday, 9 January 2020

Fiber Optics Market Qualitative Analysis Reveals Explosive Growth (2019-2026)

New York, NY 9 Jan 2020 : According to a new study published by Polaris Market, the global Fiber Optics Market is anticipated to reach USD 7 billion by 2026. The market for Fiber Optics is propelled by factors including, increasing penetration of internet, rising government funds for the development of broadband infrastructure, and intense research investments by the companies for development of innovative and new technology in the fiber optic to enable cost-savings.
 
The plastic optic fiber market is expected to notice a high growth during the projected period. The core material (polymer) used for construction of plastic optic fiber is different from the material (glass) used in single mode and multimode.
 
 
This provides a dynamic application and helps in saving cost. Further, the telecommunication application segment is dominating the market for fiber optics attributed to the escalating demand for internet in developing economies. This segment is expected to witness constant growth owing to growing telecommunication industry particularly in Asia Pacific and Middle East & Africa region.
 
 
The Asia Pacific Fiber Optics Market is anticipated to witness the highest growth followed by Middle East & Africa. Increased industrialization, increasing adoption of smart devices resulting in high demand for internet, and blooming telecommunication industry are the major factor for propelling market growth in Middle East & Africa. Further, rising fiber optics applications in medical sector is driving market growth in countries including, China, India, and Japan. Also, governments of developed nations such as US, Japan, Germany, UK, and China are significantly investing to improve their country’s security infrastructure. Thus, with the adoption of fiber optics by the government, due to the benefits delivered by it, has further resulted in increased the Fiber Optics Market growth.
 
 
Corning, one of the leading company in fiber optics market stated that the market demand is surpassing supply. The company announced its plans to spend USD 176 million in the next two years for building a new manufacturing facility for optical fiber as well as to expand its existing facility. Also, Finisa, a transceiver vendor, is also planning to construct a new manufacturing plant in China and expand its existing facility in Texas. Such development reflects the increasing market growth. The major players operating in the Fiber Optics market include Corning Incorporated, Prysmian S.p.A., Optical Cable Corporation, OFS Fitel, LLC, AFL, Furukawa Electric, Sterlite Technologies Limited, Finolex Cables Ltd., YOFC and General Cable Corporation among others.
 
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Battery Management System Market 2019 Regional Analysis, Market Share, Size, Revenue and Forecast to 2026


New York, NY 9 Jan 2020 : According to a new study published by Polaris Market Research the worldwide battery management system (BMS) market is anticipated to reach USD 14,422 million by 2026. In 2017, the lead-acid batteries dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period.

The rising demand of BMS from the automotive sector primarily drives the growth of this market. These systems are increasingly being adopted across various industries such as aerospace and defense, healthcare, and electronics among others. The increasing adoption of BMS in data centers, and renewable energy systems further supports the growth of this market.


The demand for electric vehicles has increased significantly over the years owing to increasing prices of gasoline prices across the globe, which leads to increased adoption of battery management systems. The exponential growth in the prices of gasoline and diesel owing to the depleting fossil fuel reserves has encouraged consumers to switch to battery based electric vehicles. Limited availability of public electric vehicle charging infrastructure for electric vehicles had restricted the adoption of these vehicles to a certain extent in the past. However, with significant government initiatives and substantial investments, the development of public charging infrastructure has accelerated significantly. Technological advancements in components such as lithium-ion batteries, which are majorly used in electric vehicles, along with decreasing prices of the same is expected to further increase the demand of battery based electric vehicles in the market.

North America generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The increasing demand for alternative fuel vehicles, especially the electric-vehicles is expected to drive the growth of battery management systems in this region. The growing use of BMS in renewable energy storage systems also accelerates the adoption. Asia-Pacific is expected to grow at the highest CAGR during the forecast period owing to increasing demand for BMS from countries such as China, Japan, and India. The presence of large number of automotive manufacturers and portable device suppliers also augments the growth of this market in the region.


The different types of topologies included in the report include centralized, distributed, and modular. In 2017, centralized topology accounted for the highest market share. However, during the forecast period distributed and modular topologies are expected to represent strong growth.
Modular topology offer high computational power, and enhanced safety.  Modular topology is also increasingly being used for various applications such as drones, electric vehicles, and energy storage systems among others.

The various end-users of battery management systems include medical, automotive, telecommunication, consumer electronics, military, and others. In 2017, consumer electronics accounted for the largest share in the global market, and are estimated to grow at a substantial rate during the forecast period. The automotive segment is expected to grow at the highest CAGR during the forecast period owing to increasing applications, stringent government regulations regarding vehicular emissions, increasing acceptance of electric vehicles.


The well-known companies profiled in the report include Texas Instruments Inc., Johnson Matthey PLC., Linear Technology Corporation, vecture Inc., Elithion Inc., NXP Semiconductors, Intersil Corporation, Nuvation Engineering, Ventec SAS, Generex Systems, and Lithium Balance A/S among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com






CAR T Cell Therapy Market Regional Analysis, Market Share, Size, Revenue and Forecast to 2026





New York, NY 9 Jan 2020: Global CAR T Cell Therapy Market is anticipated to reach over USD 2.99 Billion by 2025 According to a new research published by Polaris Market Research. The CAR T therapy uses the patient’s own immune system as well as develops it to target the tumor cells and execute them. This therapy is depending on the re-engineering of T-cells to make them recognize cancer cells and target such cells when they generally fail to do so. This therapy has proven very operative in patients with blood cancer who have already gone through alternative therapies such as chemotherapy.
The Choice of the Target Antigen to Define the Type of Therapy
The CD19 antigen present on the surface of the B cell has proven to be the highly effective CAR T cell therapy with approved treatment for leukemia and lymphoma where B cells have become carcinogenic. Currently, Kymriah by Novartis and Yescarta (manufactured and distributed by Kite Pharma, a subsidiary of a US-based company, Gilead Sciences) are only approved products for B Cell Acute Lymphoblastic Leukemia (ALL) and Large B-Cell lymphoma respectively. The key players in this sector are evolving new CAR-T therapies targeting different antigens for solid tumor including L1CAM, MUC16 and for blood cancers including CD123, CD22, BCMA among others.

Global Market Significance
CAR-T is a vastly revolutionary therapy which contains a distinctive business model in the pharmaceutical industry to reach the commercial stage. This therapy signifies a novel methodology with large potential in terms of manufacturing procedure and toxicity management. Leading key market players such as Novartis, Gilead, Celgene, and others are gaining full exposure to the immuno-oncology field with the ongoing merger and acquisition activities, product developments, and clinical trials to increase the importance of cellular therapy.

The Global CAR T Cell Therapy Market is segmented on the basis of the target antigen, application, and geography. On the basis of a target antigen, the global CAR T Cell Therapy Market is segmented into CD19, CD20, MESO, HER2, EGFRV III, and Others. On the basis of application, the global CAR T Cell Therapy Market is segmented into Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, and Others. The first therapy approved was observed among pediatrics and/or young adults Acute Lymphoblastic Leukemia (ALL) – an ailment with a high unmet need where CAR-T indicated high effectiveness. The therapy for Diffuse Large B-Cell Lymphoma (DLBCL) was estimated to be the largest market sharing segment followed by multiple myeloma. In addition, Chronic Lymphocytic Leukemia and follicular lymphoma are expected to be the other major market segments during the forecast period.

Have Questions? make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/inquire-before-buying

In terms of geography, North America region is estimated to dominate the global CAR T Cell Therapy Market. Increasing research and developments programs as well as ongoing regulatory approvals are factors attributed for the augmented market growth of CAR T cell therapy. For instance, Kymriah (a Novartis product) has cleared the USFDA approval in August 2017 for the treatment of patients suffering from acute lymphoblastic leukemia. Moreover, key players such as Novartis and Kite are the first to reach US market and are expected to focus on expansion via the number of academic centers that can provide appropriate cancer treatments in 2018.

Some major key players in global CAR T Cell Therapy Market includes Novartis International AG, Kite Pharma, Inc., Juno Therapeutics, Pfizer, Inc. Celgene Corporation, Cellectis, Sorrento Therapeutics, Bluebird bio, and Immune Therapeutics. The objective of the key market players is to deliver better chronic care administration while keeping the cost low.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com


Lubricants Market Analysis Production Cost Analysis, Market Development And Market Dynamics Forces

New York, NY 9 Jan 2020: According to a new research published by Polaris Market Research the lubricants market is anticipated to reach over USD 169.4 billion by 2026. In 2017, the automotive segment dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period.
The growing manufacturing industry, rapid industrialization, and modernization of industrial machinery drive the growth of this market. Other driving factors include growing automotive production, rising applications in mining industries, and increasing government initiatives to support industrial growth. However, high prices of bio-based and synthetic lubricants are expected to hamper market growth. Increasing demand from developing nations is expected provide numerous growth opportunities to the market players during the forecast period.

The demand for lubricants from the industrial sector has increased over the years. The increasing need for automation and strong growth in industries support the adoption of lubricants. In the industrial sector lubricants are used for various applications such as air compressors, transformers, heat transfer systems, auxiliary equipment, metal working, and natural gas compressors among others. Lubricants are also used in wind turbines, refrigeration, paper machines, quenching, and bearings.

Asia-Pacific generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The increasing growth of automation in manufacturing industries in the region coupled with high disposable income drives the market growth in the region. The rapid industrialization in China, Japan, and India, along with significant growth in transportation, construction, and mining industries would support market growth during the forecast period. The rising trend of bio-based lubricants, and increasing environmental concerns are expected to provide growth opportunities in the coming years.

Have Questions? make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/lubricants-market/inquire-before-buying
The different applications of lubricants include industrial, automotive, and others. In 2017, the automotive segment accounted for the highest market share. The increasing demand of lubricants from automotive, marine, and aviation sectors has increased significantly over the years. The growth in automotive industry, especially in Asia-Pacific coupled with growing disposable income and improving living standards support the growth of lubricants in automotive sector.

The well-known companies profiled in the report include Exxonmobil Corporation, Idemitsu Kosan Co. Ltd, Sinopec Limited, Royal Dutch Shell PLC., Chevron Corporation, BP PLC., Amsoil Inc., Nippon Oil, Quaker Chemical Corporation, Fuchs Petrolub AG, Total S.A., and Luk Oil among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com